Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Habermann

Showing results (51-60 of 374) with videos related to

Pageof 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2004
Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484Sandra J Horning, Edie Weller, KyungMann Kim, et al.
Annals of Surgery|December 11, 2012
Splenectomy for massive splenomegaly: long-term results and risks for mortalityTimucin Taner, David M Nagorney, Ayalew Tefferi, et al.
JCO Oncology Practice|May 7, 2024
Should All Patients With Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Receive Antibiotic Eradication Therapy for <i>Helicobacter pylori</i>?Chonlada Laoruangroj, Thomas M Habermann, Yucai Wang, et al.
BMC Medical Education|July 14, 2007
If you feed them, they will come: a prospective study of the effects of complimentary food on attendance and physician attitudes at medical grand rounds at an academic medical centerColin M Segovis, Paul S Mueller, Melissa L Rethlefsen, et al.
British Journal of Haematology|January 18, 2021
Bone involvement on PET/CT predicts event-free survival in follicular lymphoma Grade 3BFrederique St-Pierre, Stephen M Broski, Betsy R LaPlant, et al.
Leukemia & Lymphoma|December 15, 2016
Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494)Vicki A Morrison, Edie A Weller, Thomas M Habermann, et al.
The American Journal of Surgical Pathology|December 6, 2005
Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behaviorRebecca F McClure, Ellen D Remstein, William R Macon, et al.
Kidney International Reports|April 29, 2021
Risk for Significant Kidney Function Decline After Acute Kidney Injury in Adults With Hematologic MalignancyHeather P May, Erin F Barreto, Kristin C Mara, et al.
Leukemia & Lymphoma|December 29, 2004
Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab eraIrene M Ghobrial, Thomas M Habermann, Kay M Ristow, et al.
Cancer Causes & Control : CCC|April 9, 2002
Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: the Iowa women's health study (United States)James R Cerhan, Thomas M Habermann, Celine M Vachon, et al.
Pageof 38

Showing results (51-60 of 374) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2004
Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484Sandra J Horning, Edie Weller, KyungMann Kim, et al.
Annals of Surgery|December 11, 2012
Splenectomy for massive splenomegaly: long-term results and risks for mortalityTimucin Taner, David M Nagorney, Ayalew Tefferi, et al.
JCO Oncology Practice|May 7, 2024
Should All Patients With Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Receive Antibiotic Eradication Therapy for <i>Helicobacter pylori</i>?Chonlada Laoruangroj, Thomas M Habermann, Yucai Wang, et al.
BMC Medical Education|July 14, 2007
If you feed them, they will come: a prospective study of the effects of complimentary food on attendance and physician attitudes at medical grand rounds at an academic medical centerColin M Segovis, Paul S Mueller, Melissa L Rethlefsen, et al.
British Journal of Haematology|January 18, 2021
Bone involvement on PET/CT predicts event-free survival in follicular lymphoma Grade 3BFrederique St-Pierre, Stephen M Broski, Betsy R LaPlant, et al.
Leukemia & Lymphoma|December 15, 2016
Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494)Vicki A Morrison, Edie A Weller, Thomas M Habermann, et al.
The American Journal of Surgical Pathology|December 6, 2005
Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behaviorRebecca F McClure, Ellen D Remstein, William R Macon, et al.
Kidney International Reports|April 29, 2021
Risk for Significant Kidney Function Decline After Acute Kidney Injury in Adults With Hematologic MalignancyHeather P May, Erin F Barreto, Kristin C Mara, et al.
Leukemia & Lymphoma|December 29, 2004
Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab eraIrene M Ghobrial, Thomas M Habermann, Kay M Ristow, et al.
Cancer Causes & Control : CCC|April 9, 2002
Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: the Iowa women's health study (United States)James R Cerhan, Thomas M Habermann, Celine M Vachon, et al.
Pageof 38